UBS Maintains Neutral Rating on Conagra Brands (CAG)

Core Viewpoint - Conagra Brands, Inc. (NYSE:CAG) is currently facing challenges, with a recent price target cut by UBS and a decline in net sales reported for fiscal Q2 2026 [1][2]. Financial Performance - For fiscal Q2 2026, Conagra reported a net sales drop of 6.8%, with organic net sales decreasing by 3.0% [2]. - The reported diluted net loss per share was $1.39, primarily due to non-cash goodwill and brand impairment charges, while adjusted earnings per share (EPS) stood at $0.45 [3]. - The operating margin for the quarter was reported at 20.1%, with an adjusted operating margin of 11.3% [2]. Sales Dynamics - The decline in organic net sales was attributed to flat price/mix and a 3.0% decrease in volume, alongside a headwind of approximately 100 basis points from changes in retailer purchasing activity [4]. - Price/mix was further impacted by a 60 basis point headwind related to changes in estimates for fiscal 2025's trade expense accrual and an unfavorable product mix [5]. Guidance and Outlook - Conagra reaffirmed its fiscal 2026 guidance, expecting an adjusted operating margin between approximately 11.0% and 11.5%, and adjusted EPS between $1.70 and $1.85 [5]. Company Overview - Conagra Brands operates in three segments: Grocery & Snacks, Refrigerated & Frozen, and International, with a brand portfolio that includes Birds Eye, Duncan Hines, Healthy Choice, Marie Callender's, Reddi-wip, and BOOMCHICKAPOP [6].